ПАРИЖСКАЯ СИСТЕМА ИНТЕРПРЕТАЦИИ УРИНАРНОЙ ЦИТОПАТОЛОГИИ

Аннотация

В работе представлена Парижская система оценки уринарной цитопатологии, разработанная совместными усилиями цитологов, патологов и урологов в апреле 2016 г. Представлены семь принятых категорий цитологических заключений и критерии их оценки, риск озлокачествления при различной уринарной патологии и рекомендуемая тактика ведения пациентов.

Об авторах

Список литературы

Статистика злокачественных новообразований в России и странах СНГ в 2012 г. Давыдов М.И., Аксель Е.М., ред. М.: Издательская группа РОНЦ; 2014.

Пугачев В.В., Горбань Н.А., Сафиуллин К.Н., Карякин О.Б. Иммуногистохимическое исследование в оценке степени злокачественности немышечно-инвазивного папиллярного уротелиального рака мочевого пузыря. Онкоурология. 2014: 3; 49-53.

Amin M.B., Smith S.C., Reuter V.E. et al. Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer. Modern Pathology.2014; 1: 19.

Rosenthal D.L., Wojcik E.M., Kurtycz D.F.I. The Paris System for Reporting Urinary Cytology. Springer; 2016.

Galed-Placed I., Valbuena-Ruvira L. Decoy cells and malignant cells coexisting in the urine from a transplant recipient with BK virus nephropathy and bladder adenocarcinoma. Diagn Cytopathol. 2011; 39:933-7.

Geetha D., Tong B.C., Racusen L. et al. Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent. Transplantation. 2002; 73:1933-6.

Renshaw A.A. Subclassifying atypical urinary cytology specimens. Cancer. 2000; 90: 222-9.

Wojcik E.M. What should not be reported as atypia in urine cytology. J. Am. Soc. Cytopathology. 2015;4:30-6.

Piaton E., Decaussin-Petrucci M., Mege-Lechevallier F. et al. Diagnostic terminology for urinary cytology reports including the new subcategories ‘atypical urothelial cells of undetermined significance’ (AUC-US) and ‘cannot exclude high grade’(AUC-H). Cytopathology. 2014; 25:27-38.

Sternberg I., Rona R., Olsfanger S. et al. The clinical significance of class III (suspicious) urine cytology. Cytopathology. 2011; 22: 329-33.

Vanden Bussche C.J., Sathiyamoorthy S., Owens C.L. et al. The Johns Hopkins Hospital template for urologic cytology samples: parts II and III: improving the predictability of indeterminate results in urinary cytologic samples: an outcomes and cytomorphologic study. Cancer Cytopathol. 2013;121: 21-8.

Ton Nu T.N., Kassouf W., Ahmadi-Kaliji B. et al. The value of the “suspicious for urothelial carcinoma” cytology category: a correlative study of 4 years including 337 patients. Cancer Cytopathol. 2014;122: 796-803.

MurphyW.M., SolowayM.S., JukkolaA.F. et al. Urinary cytology and bladder cancer. The cellular features of transitional cell neoplasms. Cancer. 1984; 53: 1555-65.

Raab S.S., Lenel J.C., Cohen M.B. Low grade transitional cell carcinoma of the bladder. Cytologic diagnosis by key features as identified by logistic regression analysis. Cancer. 1994; Sep. 1; 74 (5): 1621-6.

Hughes J. H., Raab S. S., Cohen M. B. The cytologic diagnosis of low-grade transitional cell carcinoma. Am. J. Clin. Pathol. 2000; 114: 59-67.

Xin W., Raab S. S., Michael C. W. Low-grade urothelial carcinoma: reappraisal of the cytologic criteria on ThinPrep. Diagn. Cytopathol. 2003; 29 (3):125-9.

Mai K. T., Ball C. G., Kos Z. et al. Three-dimensional cell groups with disordered nuclei and cellular discohesion (3DDD) are associated with high sensitivity and specificity for cystoscopic urine cytopathological diagnosis of low-grade urothelial neoplasia. Diagn. Cytopathol. 2014;42(7):555-63.

Nathan N.A., Narayan E., Smith M.M., Horn M.J. Cell block cytology. Improved preparatlon and its efficacy in diagnostic cytology. Am. J. Clin. Pathol. 2000;114: 599-606.

Reid M.D., Osunkoya A.О., Siddiqui M.T., Looney S.W. Accuracy of grading of urothelial carcinoma on urine cytology: an analysis of interobserver and intraobserver agreement. Int. J. Clin. Exp. Pathol. 2012; 5: 882-91.

Raab S.S., Grzybicki D.M., Vrbin C.M., Geisinger K.R. Urine cytology discrepancies: frequency, causes, and outcomes. Am.J. Clin. Pathol. 2007;127: 946-53.

Rosenthal D.L., Vandenbussche C.J., Burroughs F.H. et al. The Johns Hopkins Hospital template for urologic cytology samples: part I-creating the template. Cancer Cytopathol. 2013;121:15-20.

Ubago J.M., Mehta V. Wojcik E.M., Barkan G.A. Evaluation of atypical urine cytology progression to malignancy. Cancer Cytopathol. 2013;121: 387- 91.

Koss L.G., Hoda R.S. Koss’s cytology of the urinary tract with histopathologic correlations. New York: Springer Press; 2012.

Hoda R.S. Non-gynecologic cytology on liquid-based preparations: 3 morphologic review of facts and artifacts. Diagn. Cytopathol. 2007; 35:621-34.

Khaled H. Schistosomiasis and cancer in Egypt review. J. Adv. Res. 2013; 4: 461- 6.

Hattori M., Nishimura Y., Toyonaga M. et al. Cytological significance of abnormal squamous cells in urinary cytology. Diagn. Cytopathol. 2012;40: 798-803.

Gulmann C., Paner G.P., Parakh R.S. et al. Immunohistochemical profile to distinguish urothelial from squamous differentiation in carcinomas of urothelial tract. Hum. Pathol. 2013; 44: 164-72.

Zhong M., Gersbach E., Rohan S.M., Yang X.J. Primary adenocarcinoma of the urinary bladder: differential diagnosis and clinical relevance. Arch. Pathol. Lab. Med. 2013; 137; 371-81.

Bardales R.H., Pitman M.B., Stanley M.W. et al. Urine cytology of primary and secondary urinary bladder adenocarcinoma. Cancer. 1998; 34: 335-43.

Ciesla M.C., Guidos B.J., Selvaggi S.M. Cytomorphology of small-cell (neuroendocrine) carcinoma on ThinPrep cytology as compared to conventional smears. Diagn. Cytopathol. 2001; 24: 46-52.

Dahm P., Gschwend J.E. Malignant non-urothelial neoplasms of the urinary bladder: a review. Eur. Urol. 2003; 44: 672-81.

Chalasani V, Chin J.L., Izawa J.I. Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer. Can. Urol. Assoc. J. 2009; 3(6): l93-8.

Westfall D.E., Folpe A.L., Paner G.P. et al. Utility of a comprehensive immunohistochemical panel in the differential diagnosis of spindle cell lesions of the urinary bladder. Am.J.Surg.Pathol. 2009; 33: 99-105.

Cheson B.D., Schumann J.L., Schumann G.B. Urinary cytodiagnostic abnormalities in 50 patients with non-Hodgkin’s lymphomas. Cancer. 1984; 54: 1914-9.

Jimenez-Hernandez M., Lopez-Guillermo A., Cobo F. et al. Bladder involvement of diffuse large B-cell lymphoma diagnosed by a cytological study of the urine. Leuk. Lymphoma. 2002; 43: 187-9.

Khalbuss W.E., Hossain M., Elhosseiny A. Primary malignant melanoma of the urinary bladder diagnosed by urine cytology: a case report. Acta Cytol. 2001;45:631-5.

Xiao G.Q., Chow J., Unger P.D. Metastatic tumors to the urinary bladder. Clinicopathologic study of 11 cases. Int.J.Surg.Pathol. 2012; 20: 342-8.

Abol-Enein H., Kava B.R., Carmack A.J. Nonurothelial cancer of the bladder. Urology. 2007; 69 (1): 93-104.

Ключевые слова